DNA nanoparticle formulations for optimal ocular gene delivery

用于最佳眼部基因传递的 DNA 纳米颗粒配方

基本信息

  • 批准号:
    8545860
  • 负责人:
  • 金额:
    $ 42.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-30 至 2015-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this program is to advance current DNA nanoparticle (NP) delivery and expression technologies to develop safe and effective therapies for important ocular disorders affecting the photoreceptor (PR) and retinal pigment epithelial (RPE) cells. The program will merge experts with molecular bioengineering, vision science, physics, and chemistry to accelerate essential steps for the generation of effective ocular non-viral gene therapy. The DNA NPs consist of single molecules of DNA compacted with lysine-PEG polycations and have a minimum diameter of 8-11 nm. Their small size, coupled with a specific uptake mechanism that efficiently traffics the NPs to the nucleus and bypasses the lysosomal degradation system, likely accounts for the ability of the NPs to robustly transfect post-mitotic, differentiated cells. The counter-ion used at the time of formulation determines the NP shape and both rod-like and ellipsoidal NPs show robust transfection of ocular cells, including RPE, PRs and retinal ganglion cells (RGCs). Moreover, murine RDS NPs have demonstrated partial phenotypic correction in a retinitis pigmentosa mouse model of RDS haploinsufficiency. Having previously shown proof-of-principle for the effective use of these NPs in the eye, in this application we will take the necessary steps to optimize the particles for clinical ocular use. First, we will optimize the NP formulation (NP shape, size, and chemical composition) for PR- and RPE-specific gene transfer (Aim #1). Second, we will engineer clinically-appropriate DNA vectors (Aim #2) to generate persistent, high levels of transgene expression. Thirds, we will test the ability of these NPs to target the macula in a non-human primate model (baboon) (Aim #3) including an assessment of whether non-invasive intravitreal delivery of NPs can transfect macular/foveal cones. This is a novel and critical development for clinical application of this technology, as many retinal degenerations target the macula. Furthermore, it is a step that cannot be modeled by a mouse system due to the absence of a macula in the rodent retina. We will also conduct toxicology and DNA biodistribution studies in baboons, including a detailed evaluation of brain visual pathways. Building on the documented ability of the current NP formulation to penetrate deep retinal layers, we hypothesize that this efficiency can be improved by the NP formulation optimization program detailed in Aim #1, enabling robust foveal cone gene transfer. In summary, results from this application will facilitate preclinical trial evaluations of DNA NPs for ocular gene delivery.
描述(由申请人提供):该项目的目标是推进当前的DNA纳米颗粒(NP)传递和表达技术,以开发安全有效的治疗影响光感受器(PR)和视网膜色素上皮(RPE)细胞的重要眼部疾病。该项目将整合分子生物工程、视觉科学、物理和化学方面的专家,以加速产生有效的眼部非病毒基因治疗的关键步骤。DNA NPs由DNA单分子与赖氨酸-聚乙二醇聚合组成,最小直径为8- 11nm。它们的小尺寸,加上特定的摄取机制,有效地将NPs运输到细胞核,绕过溶酶体降解系统,可能解释了NPs强大转染有丝分裂后分化细胞的能力。配制时使用的反离子决定了

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Muna I. Naash其他文献

Characterization of glutathione peroxidase in frog retina.
青蛙视网膜谷胱甘肽过氧化物酶的表征。
  • DOI:
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Muna I. Naash;Robert E. Anderson
  • 通讯作者:
    Robert E. Anderson
882. Non-Viral Ocular Gene Transfer for Hereditary Retinal Degeneration
  • DOI:
    10.1016/j.ymthe.2006.08.971
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Muna I. Naash;Ron M. Ballard;Jeff Skaggs;Zack Nash;Alexander B. Quiambao;Mark J. Cooper;Rafal Farjo
  • 通讯作者:
    Rafal Farjo
The regional distribution of vitamins E and C in mature and premature human retinas.
维生素 E 和 C 在成熟和早产人类视网膜中的区域分布。
Correction: Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones
  • DOI:
    10.1007/s00018-023-04929-y
  • 发表时间:
    2023-09-12
  • 期刊:
  • 影响因子:
    6.200
  • 作者:
    Larissa Ikelle;Mustafa Makia;Tylor Lewis;Ryan Crane;Mashal Kakakhel;Shannon M. Conley;James R. Birtley;Vadim Y. Arshavsky;Muayyad R. Al-Ubaidi;Muna I. Naash
  • 通讯作者:
    Muna I. Naash

Muna I. Naash的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Muna I. Naash', 18)}}的其他基金

Vector engineering for non-viral delivery of large genomic DNA to the RPE
用于将大基因组 DNA 非病毒传递至 RPE 的载体工程
  • 批准号:
    10667049
  • 财政年份:
    2023
  • 资助金额:
    $ 42.41万
  • 项目类别:
Non-viral gene delivery platforms for the treatment of Usher Syndrome Type 2A.
用于治疗 2A 型亚瑟综合症的非病毒基因递送平台。
  • 批准号:
    10578428
  • 财政年份:
    2023
  • 资助金额:
    $ 42.41万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    8504140
  • 财政年份:
    2013
  • 资助金额:
    $ 42.41万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    8677899
  • 财政年份:
    2013
  • 资助金额:
    $ 42.41万
  • 项目类别:
DNA nanoparticle formulations for optimal ocular gene delivery
用于最佳眼部基因传递的 DNA 纳米颗粒配方
  • 批准号:
    8734431
  • 财政年份:
    2012
  • 资助金额:
    $ 42.41万
  • 项目类别:
DNA nanoparticle formulations for optimal ocular gene delivery
用于最佳眼部基因传递的 DNA 纳米颗粒配方
  • 批准号:
    8365445
  • 财政年份:
    2012
  • 资助金额:
    $ 42.41万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    7353945
  • 财政年份:
    2008
  • 资助金额:
    $ 42.41万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    8007344
  • 财政年份:
    2008
  • 资助金额:
    $ 42.41万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    8204931
  • 财政年份:
    2008
  • 资助金额:
    $ 42.41万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    8134621
  • 财政年份:
    2008
  • 资助金额:
    $ 42.41万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了